Trevor Bedford
See the following -
Open Data Projects Win Wellcome Trust, NIH and HHMI Open Science Prize
The Open Science Prize, a new initiative from the US National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI) and the Wellcome Trust, encourages and supports open science approaches that generate benefit to society, advance research and spur innovation. An integral component of the selection process is demonstrated use and generation of open data, so PLOS is proud that this year’s winner of the Open Science Prize is PLOS author and evolutionary, computational biologist Trevor Bedford of the Fred Hutchinson Cancer Research Center in Seattle, Washington...
- Login to post comments
Open Science Prize Announces Epidemic Tracking Tool as Grand Prize Winner
A prototype online platform that uses real-time visualization and viral genome data to track the spread of global pathogens such as Zika and Ebola is the grand prize winner of the Open Science Prize. The international team competition is an initiative by the National Institutes of Health, in collaboration with the Wellcome Trust and the Howard Hughes Medical Institute (HHMI). The winning team, Real-time Evolutionary Tracking for Pathogen Surveillance and Epidemiological Investigation, created its nextstrain.org prototype to pool data from researchers across the globe, perform rapid phylogenetic analysis, and post the results on the platform’s website...
- Login to post comments
The Need for Speed - It's Time to Act!
As a society we also need to get moving on the population level as well - and the sooner the better! In his fascinating genomic epidemiology detective work Trevor Bedford conducted based on the COVID-19 research he and his team had done in the Bedford lab in Seattle WA, he concluded that the narrow testing that was done in the Seattle area in the early days of the Coronavirus spread allowed the virus to spread faster. In contrast, the Coronavirus testing-blitz in South Korea appears to keep the death rate lower than it could be. It's time to test! The FDA gave high-tech labs the green light to operate tests before receiving any agency review or authorization and both Quest Diagnostics and LabCorp already announced that they have test in the market. But according to CDC, as of March 8 there were only 1,707 tests performed in the US vs. 189,236 in South Korea.
- Login to post comments